Quickly-dissolved atorvastatin calcium tablet and preparation method thereof

An atorvastatin calcium and rapid technology, applied in the direction of pill delivery, metabolic diseases, active ingredients of heterocyclic compounds, etc., can solve the problems of reduced pharmacological activity, poor stability, complicated process, etc., to increase drug safety and reduce viscosity Increase, the effect of simple preparation process

Inactive Publication Date: 2013-04-03
QINGDAO UNIV
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The clinical curative effect of atorvastatin calcium is definite and remarkable. However, the drug is very slightly soluble in water and has poor stability. It is highly sensitive to humidity, heat, light and acidic environment, especially in acidic environment, it will degrade into Lactone reduces pharmacological activity. After testing, the dissolution rate of commercially available products (Lipitor, batch number 031610K, Pfizer Pharmaceuticals) in pH 1.2 hydrochloric acid medium is about 36% in 10 minutes. How to improve the dissolution rate of drugs in acidic medium has always been bothering pharmacists
[0006] CN1630510A discloses a kind of technology, adopts wet granulation technology, adds calcium carbonate as stabilizer in prescription, to guarantee that medicine is in alkaline environment, avoids medicine degradation, but a large amount of calcium carbonate can react with stomach acid, causes cons

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quickly-dissolved atorvastatin calcium tablet and preparation method thereof
  • Quickly-dissolved atorvastatin calcium tablet and preparation method thereof
  • Quickly-dissolved atorvastatin calcium tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] (1) atorvastatin calcium 1 part

[0031] Methanol 10 parts

[0032] 0.3 parts of crospovidone

[0033] (2) 20 servings of lactose pellets

[0034] (3) 50 parts of microcrystalline cellulose

[0035] Crospovidone 0.5 parts

[0036] 1 part magnesium stearate

[0037] Preparation Process:

[0038] The raw material of atorvastatin calcium is dissolved in methanol, crospovidone is added, and ground by a ball mill to control the particle size of the suspension d90<20 μm. Then coating is carried out in a fluidized bed, the suspension is coated on the outer layer of lactose pellets, after the coating is completed, it is evenly mixed with microcrystalline cellulose, crospovidone and magnesium stearate, and compressed into tablets to obtain the product.

Embodiment 2

[0040] (1) atorvastatin calcium 1 part

[0041] Methanol 10 parts

[0042] 3 parts crospovidone

[0043] (2) 20 servings of lactose pellets

[0044] (3) 50 parts of microcrystalline cellulose

[0045] 3.5 parts of crospovidone

[0046] 1 part magnesium stearate

[0047] Preparation Process:

[0048] The raw material of atorvastatin calcium is dissolved in methanol, crospovidone is added, and ground by a ball mill to control the particle size of the suspension d90<20 μm. Then coating is carried out in a fluidized bed, the suspension is coated on the outer layer of lactose pellets, after the coating is completed, it is evenly mixed with microcrystalline cellulose, crospovidone and magnesium stearate, and compressed into tablets to obtain the product.

Embodiment 3

[0050] (1) atorvastatin calcium 1 part

[0051] Methanol 10 parts

[0052] Sodium carboxymethyl starch 0.3 parts

[0053] (2) Mannitol pellets 20 parts

[0054] (3) 50 parts of microcrystalline cellulose

[0055] Crospovidone 0.5 parts

[0056] 1 part magnesium stearate

[0057] Preparation Process:

[0058] The raw material of atorvastatin calcium is dissolved in methanol, crospovidone is added, and ground by a ball mill to control the particle size of the suspension d90<20 μm. Then coat in a fluidized bed, wrap the suspension on the outer layer of mannitol pellets, mix evenly with microcrystalline cellulose, crospovidone, and magnesium stearate after coating, and press into tablets to obtain .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a quickly-dissolved atorvastatin calcium tablet and a preparation method thereof. The atorvastatin calcium tablet provided by the invention does not contain surface active agents and alkaline materials, is simple in process, and can be quickly dissolved in the stomach, thereby enhancing the compliance and treatment effect of the administration of patients.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a fast-dissolving atorvastatin calcium tablet and a preparation method thereof. Background technique [0002] Atorvastatin is a new type of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, which has the effect of lowering serum cholesterol and triacylglycerol at the same time, and its lipid-lowering effect is higher than that of other HMGs - CoA reductase inhibitors. Atorvastatin reduces plasma cholesterol and serum lipoprotein concentrations by inhibiting HMG-CoA reductase and cholesterol biosynthesis in the liver, and enhances the uptake and metabolism of LDL-C by increasing liver LDL receptors on the cell surface , reduce the synthesis of LDL-C and the number of particles, thereby reducing LDL-C and TC, and have the effect of reducing TG, HDL-C is also slightly increased. [0003] The structural formula of atorvastatin calc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K31/40A61P3/06
Inventor 孙勇徐丽洒徐平刘巧囡沈若武
Owner QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products